Amgen Inc Sample Contracts

AutoNDA by SimpleDocs
EXHIBIT 7.11
Purchase Agreement • March 22nd, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • New York
BY AND AMONG AMGEN INC.,
Agreement and Plan of Merger • December 17th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 1.1 UNDERWRITING AGREEMENT
Underwriting Agreement • December 5th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • New York
FIRST AMENDMENT TO CREDIT AGREEMENT
Credit Agreement • March 24th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • California
Amgen Inc. and
Rights Agreement • December 18th, 2000 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMGEN INC.
Terms Agreement • December 9th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 1 TO WARRANT AGREEMENT
Warrant Agreement • March 7th, 2000 • Amgen Inc • Biological products, (no disgnostic substances) • New York
OF
License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 7.3 =================================================================== ============= REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • October 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 4 TO -- SHAREHOLDERS' AGREEMENT ----------------------- OF -- KIRIN-AMGEN, INC. -----------------
Assignment Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
AGREEMENT ---------
Rights Agreement • February 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
Amgen Inc. and
Rights Agreement • February 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 2 _ --------------- _TO
License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
ARTICLE 1 DEFINITIONS AND ACCOUNTING TERMS
Credit Agreement • August 6th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • New York
by and between
License Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • California
between AMGEN INC. and
Registration Rights Agreement • November 19th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • New York
AMGEN INC.
Purchase Agreement • November 19th, 2004 • Amgen Inc • Biological products, (no disgnostic substances) • New York
AutoNDA by SimpleDocs
AMGEN INC. AND
Amgen Inc • March 14th, 1997 • Biological products, (no disgnostic substances) • New York
EXHIBIT 7.1 =================================================================== ============= STOCK AND WARRANT PURCHASE AGREEMENT
Stock and Warrant Purchase Agreement • October 28th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 7
Shareholders' Agreement • March 7th, 2001 • Amgen Inc • Biological products, (no disgnostic substances)
EXHIBIT 10.52 ASTERISKS (*) INDICATE CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH THE SEC. HEADS OF AGREEMENT
Heads of Agreement • August 12th, 1997 • Amgen Inc • Biological products, (no disgnostic substances)
FORM OF FIXED RATE MEDIUM-TERM NOTE [FACE OF NOTE]
Amgen Inc • December 9th, 1997 • Biological products, (no disgnostic substances)

THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (THE "DEPOSITARY") OR A NOMINEE THEREOF. THIS NOTE IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.

Registration Rights Agreement Dated As of February 17, 2006 between Amgen Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated
Registration Rights Agreement • February 21st, 2006 • Amgen Inc • Biological products, (no disgnostic substances) • New York

This Registration Rights Agreement (the “Agreement”) is made and entered into this 17th day of February, 2006, among Amgen Inc., a Delaware corporation (the “Company”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and Morgan Stanley & Co. Incorporated (“Morgan Stanley”), acting on behalf of the several parties named in Schedule A to the Purchase Agreement (as defined below) (collectively, the “Initial Purchasers”).

Time is Money Join Law Insider Premium to draft better contracts faster.